Novel therapeutic strategy in the treatment of infectious diseases by anti-microbial, endotoxin-neutralizing proteins.
Novel therapeutic strategy in the treatment of infectious diseases by anti-microbial, endotoxin-neutralizing proteins.
批准号:
10670267
负责人:
HIRATA Michimasa
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have found 18kDa cationic anti-microbial proteins (CAP18) with LPS-neutralizing activity from rabbit and human neutrophils. The 27mer C-terminal fragment of human CAP 18 (27mer ; CAP18_<109-135>) has been identified as the anti-microbial and LPS-neutralizing domain. We investigated the effects of modification and/or substitution of amino acid residues of CAP18 peptides on their activities. Acetylation of N-terminal and amidation of C-terminal residues of the 27mer in-creased LPS-neutralizing and antimicrobial activities. Substitution of E_<119> and K_<128> of 27mer to L (27LL) or F (27FF) increased LPS binding activity (〜30-40 fold) and also blocked LPS-induced lethality in mice. Substitution of E_<119> to L_<119> increased LPS-binding activity (〜8 -fold), however, this peptide (27L) could not protect vs. endotoxin shock. Truncation of 9 amino acids from the N-terminus of 27mer (18mer : CAP18_<118-135>) resulted in a significant decrease in LPS-binding activity even though both terminuses are chemically modified. Increasing the hydrophobic amino acid residues (Leucin=L) in 18mer (18LL) increased LPS-binding activity (〜30-fold) and anti-microbial activity versus gram-positive bacteria such as MRSA (methicillin resistant staphylococcus aureus ; >3 -folds), however, 18LL could not protect vs. endotoxin shock in mice. Further replacement of three positions of 18LL by lysine (K) significantly increased LPS-binding activity (〜120-fold), antimicrobial activity vs. gram negative bacteria such as E.coli O157 : H7 and S.typhimurium, and protect mice from endotoxin shock.From these results, the importance of the stability of alpha-helical structure, and the balance of hydrophobic/ hydrophilic (basic) amino acid residues in CAP18 peptide was suggested.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
平田陸正: "エンドトキシン研究I.-基礎と臨床-"菜根出版. 230 (1998)
Rikumasa Hirata:“内毒素研究 I.-基础和临床”Nane Publishing 230(1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
平田 陸正(分担): "エンドトキシン研究シリーズI" 菜根出版, 230 (1998)
平田陆政(撰稿人):《内毒素研究系列 I》Nane Publishing,230(1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Swlerzko,AS.: "Biological activities of lipopolysaccharides of proteus spp.and their interactions with polymyxin B and an 18-kDa cationic antimicrobial protein (CAP18)-derived peptide."J.Med.Microbiol.. 49. 127-138 (2000)
Swlerzko, AS.:“变形杆菌属脂多糖的生物活性及其与多粘菌素 B 和 18-kDa 阳离子抗菌蛋白 (CAP18) 衍生肽的相互作用。”J.Med.Microbiol.. 49. 127-138 (2000
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Haishima,Y: "Chemical and biological evaluation of endotoxin contamination on natural latex products."J.Biochem.Mater.Res. (印刷中). (2001)
Haishima,Y:“天然乳胶产品内毒素污染的化学和生物学评估。”J.Biochem.Mater.Res(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nagaoka I: "Evaluation of the expression of human CAP18 gene during neutrophil maturation in the bone marrow." J.Leukoc.Biol.64. 845-852 (1998)
Nagaoka I:“评估骨髓中性粒细胞成熟过程中人类 CAP18 基因的表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 27 条
Endotoxin binding protein : Novel therapeutic strategy of endotoxin shock.
-
批准号:08670314
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.66万
-
财政年份:1996
-
负责人:HIRATA Michimasa
-
依托单位:
The Role of Endotoxin-neutralizing and Antimicrobial Proteins in Innate Immunity
-
批准号:06670300
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1994
-
负责人:HIRATA Michimasa
-
依托单位:
Role of Endotoxin-binding proteins in Non-specific Protection to Infection
-
批准号:04670250
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1992
-
负责人:HIRATA Michimasa
-
依托单位:
Elucidation of the mechanism of endotoxin-induced disseminated intravascular coagulation; Tissue factor activity in macrophage and granulocyte.
-
批准号:61570214
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:1986
-
负责人:HIRATA Michimasa
-
依托单位:
海外基金